These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33160273)

  • 21. Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.
    Kershner LJ; Choi K; Wu J; Zhang X; Perrino M; Salomonis N; Shern JF; Ratner N
    JCI Insight; 2022 Sep; 7(18):. PubMed ID: 36134665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline and somatic NF1 gene mutations in plexiform neurofibromas.
    Upadhyaya M; Spurlock G; Monem B; Thomas N; Friedrich RE; Kluwe L; Mautner V
    Hum Mutat; 2008 Aug; 29(8):E103-11. PubMed ID: 18484666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.
    Grit JL; Johnson BK; Dischinger PS; J Essenburg C; Adams M; Campbell S; Pollard K; Pratilas CA; Triche TJ; Graveel CR; Steensma MR
    Epigenetics Chromatin; 2021 Jan; 14(1):7. PubMed ID: 33436083
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Chaney KE; Perrino MR; Kershner LJ; Patel AV; Wu J; Choi K; Rizvi TA; Dombi E; Szabo S; Largaespada DA; Ratner N
    Cancer Res; 2020 Nov; 80(21):4720-4730. PubMed ID: 32816910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.
    Hirbe AC; Dahiya S; Miller CA; Li T; Fulton RS; Zhang X; McDonald S; DeSchryver K; Duncavage EJ; Walrath J; Reilly KM; Abel HJ; Pekmezci M; Perry A; Ley TJ; Gutmann DH
    Clin Cancer Res; 2015 Sep; 21(18):4201-11. PubMed ID: 25925892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The
    White EE; Rhodes SD
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
    Brossier NM; Carroll SL
    Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.
    Rhodes SD; He Y; Smith A; Jiang L; Lu Q; Mund J; Li X; Bessler W; Qian S; Dyer W; Sandusky GE; Horvai AE; Armstrong AE; Clapp DW
    Hum Mol Genet; 2019 Aug; 28(16):2752-2762. PubMed ID: 31091306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.
    Hummel TR; Jessen WJ; Miller SJ; Kluwe L; Mautner VF; Wallace MR; Lázaro C; Page GP; Worley PF; Aronow BJ; Schorry EK; Ratner N
    Clin Cancer Res; 2010 Oct; 16(20):5048-57. PubMed ID: 20739432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
    Friedrich RE; Nörnberg LKN; Hagel C
    Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
    Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
    BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed rectifier K currents in NF1 Schwann cells. Pharmacological block inhibits proliferation.
    Fieber LA; González DM; Wallace MR; Muir D
    Neurobiol Dis; 2003 Jul; 13(2):136-46. PubMed ID: 12828937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclassification of nerve sheath tumors by gene expression profiling.
    Holtkamp N; Reuss DE; Atallah I; Kuban RJ; Hartmann C; Mautner VF; Frahm S; Friedrich RE; Algermissen B; Pham VA; Prietz S; Rosenbaum T; Estevez-Schwarz L; von Deimling A
    Brain Pathol; 2004 Jul; 14(3):258-64. PubMed ID: 15446580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.
    Park GH; Lee SJ; Yim H; Han JH; Kim HJ; Sohn YB; Ko JM; Jeong SY
    Oncol Rep; 2014 Oct; 32(4):1347-54. PubMed ID: 25109740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
    Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
    Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.
    Pacot L; Sabbagh A; Sohier P; Hadjadj D; Ye M; Boland-Auge A; Bacq-Daian D; Laurendeau I; Briand-Suleau A; Deleuze JF; Margueron R; Vidaud M; Ferkal S; Parfait B; Vidaud D; ; Pasmant E; Wolkenstein P
    Br J Dermatol; 2024 Jan; 190(2):226-243. PubMed ID: 37831592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
    Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
    Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.
    Li H; Zhang X; Fishbein L; Kweh F; Campbell-Thompson M; Perrin GQ; Muir D; Wallace M
    Cancer Biol Ther; 2010 Oct; 10(8):758-64. PubMed ID: 20699653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.